-+ 0.00%
-+ 0.00%
-+ 0.00%

3 Australian Growth Stocks With Revenue Growth Up To 65%

Simply Wall St·09/24/2026 15:33:20
Listen to the news

Global government bond yields are nearing 4%, a level not seen since 2007, which is lifting borrowing costs and putting pressure on richly priced shares. In that kind of market, fast growing but financially robust Australian companies can draw attention from investors who still want growth but with balance sheet discipline. This article highlights three stocks from a high growth, financially healthy screener that fit that brief.

The three stocks featured below are only a small sample. The full screen surfaces 94 more companies that share similar growth potential and financial resilience but are not covered in this article.

If you want to quickly identify, compare, and analyze those extra opportunities side by side, head straight to the Healthy high growth potential screener.

4DMedical (ASX:4DX)

4DMedical is a medical technology company focused on non invasive four dimensional respiratory imaging, with its XV Scanner, XV LVAS and CT:VQ software forming the core of its healthy high growth potential profile by targeting more precise lung function assessment in hospitals and clinics.

The business currently generates about A$7 million in revenue from medical technology research and development of lung function analysis, while the stock carries a market value of roughly A$2.4b.

For this screener, 4DMedical matters because its lung imaging platform is built for scale in a respiratory care market where better diagnostics can quickly change referral patterns and recurring software usage.

Partnership with Philips promised a $10Million USD minimum order commitment contract over the next 2 years starting December 2025 (over 2026 and 2027). Philips has added 4DMedicals CT:VQ technology as an official product on their catalog in North America.

What happens to 4DMedical’s growth story depends heavily on how one still untested piece of this rollout shapes long term demand and margins.

That hinges on how investors weigh that still untested rollout against the upside in respiratory imaging, which is exactly what the full narrative for 4DMedical unpacks with extra context on risk and runway.

ASX:4DX Earnings & Revenue Growth as at Sep 2026
ASX:4DX Earnings & Revenue Growth as at Sep 2026

Netwealth Group (ASX:NWL)

Netwealth Group runs an Australian wealth platform where advisers and retail clients use its superannuation, managed account and investment wrap services, which together generated about A$390 million from platform operations. All of that income comes from Australia, and the stock is valued at roughly A$4.6b.

Netwealth Group matters for this healthy high growth potential screen because its fee based platform model leans on advisers shifting more client money into one place, creating recurring income tied to the depth of those relationships rather than one off transactions.

Netwealth's continued investment in best‑in‑class digital experience, platform functionality, and data analytics aligns with the ongoing digitisation of financial services and increasing regulatory focus on transparency. This positions the company to capture greater adviser and client net inflows, bolster revenue growth, and strengthen platform stickiness.

What really decides how that story plays out is whether one quiet pressure on future profitability breaks in Netwealth’s favour or against it.

Whether that pressure turns into a margin squeeze or an opportunity is exactly what the full narrative for Netwealth Group lays out, including where Netwealth Group could still accelerate.

ASX:NWL Revenue & Expenses Breakdown as at Sep 2026
ASX:NWL Revenue & Expenses Breakdown as at Sep 2026

Megaport (ASX:MP1)

Megaport runs a software defined network that lets enterprises turn on cloud and data center connections as needed. This aligns with the healthy high growth potential theme and generates about A$198 million from the Americas, A$70 million from Asia Pacific and A$44 million from Europe, with the stock valued near A$4.7b.

Megaport plugs into this screener as a pure play on-demand connectivity provider, where its software defined platform is central to the growth story analysts are watching.

Skyrocketing enterprise bandwidth, surging AI/cloud adoption, and the rapid proliferation of data centers are combining to create secular tailwinds. Megaport's automation, global reach, and software-defined architecture give it the ability to be the connectivity backbone for AI factories, data-native SaaS, and hybrid enterprise networks.

What really matters is whether one quiet pressure on Megaport’s funding and profitability path makes that growth engine compounding or costly.

If that funding question is what you are wrestling with, the full narrative for Megaport shows how Megaport’s growth engine, capital needs, and competitive position really line up.

ASX:MP1 Earnings & Revenue Growth as at Sep 2026
ASX:MP1 Earnings & Revenue Growth as at Sep 2026

Seeking Fresh Alternatives Beyond These Three

Fresh ideas move first, not last. Breakout trends, new momentum, and under the radar stories often get caught late. Scan these curated picks before the crowd and consider them promptly.

  • Target steadier paydays by reviewing a curated group of income heavyweights screened as 3 dividend fortresses while yields still look appealing and sentiment has not fully caught up.
  • Explore early movers in digital assets with a focused basket of 20 cryptocurrency and blockchain stocks before regulatory headlines or hype cycles influence pricing and volumes.
  • Consider positioning for structural demand in critical minerals using a hand picked lineup from the 36 best rare earth metal stocks while supply stories and new projects remain relatively under the radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.